Holy Stone Healthcare Co (ROCO:4194) EBIT: NT$-111.06 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4194 Holy Stone Healthcare Co Ltd ROCO:4194
45 GF Score
Price NT$6.99
GF Value NT$3.93
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Holy Stone Healthcare Co EBIT?

Holy Stone Healthcare Co ROCO:4194 +4.33% 45 EBIT is NT$-111.06 Mil as of Dec. 2025. GuruFocus rates ROCO:4194 with a GF Score™ of 45/100 and a GF Value™ of NT$3.93 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Holy Stone Healthcare Co's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was NT$-67.72 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-111.06 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Holy Stone Healthcare Co's annualized ROC % for the quarter that ended in Dec. 2025 was -225.05%. Holy Stone Healthcare Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -240.14%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Holy Stone Healthcare Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -12.52%.

Holy Stone Healthcare Co  (ROCO:4194) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Holy Stone Healthcare Co's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-142.68 * ( 1 - 0% )/( (66.781 + 60.018)/ 2 )
=-142.68/63.3995
=-225.05 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=288.939 - 24.898 - ( 206.541 - max(0, 30.075 - 227.335+206.541))
=66.781

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=220.518 - 26.743 - ( 144.11 - max(0, 31.191 - 164.948+144.11))
=60.018

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Holy Stone Healthcare Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-135.438/( ( (59.421 + max(-8.402, 0)) + (53.378 + max(-10.432, 0)) )/ 2 )
=-135.438/( ( 59.421 + 53.378 )/ 2 )
=-135.438/56.3995
=-240.14 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 16.496) - (24.898 + 0 + 0)
=-8.402

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 16.311) - (26.743 + 0 + 0)
=-10.432

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Holy Stone Healthcare Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=-111.062/887.184
=-12.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Holy Stone Healthcare Co EBIT Related Terms

Holy Stone Healthcare Co EBIT Historical Data

* Premium members only.

The historical data trend for Holy Stone Healthcare Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Holy Stone Healthcare Co EBIT Chart

Holy Stone Healthcare Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -175.63 -145.81 -283.72 -182.83 -111.06

Holy Stone Healthcare Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -151.10 -86.92 -95.91 -43.34 -67.72

ROCO:4194 vs VRTX, REGN, ALNY: EBIT Comparison

For the Biotechnology subindustry, Holy Stone Healthcare Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Holy Stone Healthcare Co EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Holy Stone Healthcare Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Holy Stone Healthcare Co's EV-to-EBIT falls into.


ROCO:4194
45GF Score
Holy Stone Healthcare Co Ltd ROCO:4194
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Holy Stone Healthcare Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-111.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of NT$-111.06 Mil mean?
Holy Stone Healthcare Co (ROCO:4194) has a EBIT of NT$-111.06 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Holy Stone Healthcare Co.
Is Holy Stone Healthcare Co's EBIT too high?
Holy Stone Healthcare Co's current EBIT is NT$-111.06 Mil. Overall, Holy Stone Healthcare Co has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Holy Stone Healthcare Co's EBIT compare to VRTX and REGN?
Holy Stone Healthcare Co's EBIT of NT$-111.06 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Biotechnology company?
A good EBIT depends on the Biotechnology industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Holy Stone Healthcare Co. Holy Stone Healthcare Co's current EBIT is NT$-111.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Holy Stone Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Holy Stone Healthcare Co (ROCO:4194) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$3.93, compared to a current price of NT$6.99 — trading 77.9% above its estimated fair value. The current EBIT is NT$-111.06 Mil. Holy Stone Healthcare Co's overall GF Score™ is 45/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Holy Stone Healthcare Co (ROCO:4194), the current EBIT is NT$-111.06 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Holy Stone Healthcare Co (ROCO:4194) Overvalued in 2026?

Based on GuruFocus' analysis, Holy Stone Healthcare Co stock appears to be overvalued. The current stock price of NT$6.99 is trading 77.9% above its estimated GF Value™ of NT$3.93. GuruFocus considers Holy Stone Healthcare Co to be Significantly Overvalued.

Key valuation signals for ROCO:4194:

  • EBIT: NT$-111.06 Mil
  • GF Value™: NT$3.93 vs. price of NT$6.99 (77.9% above fair value)
  • GF Score™: 45/100 with 2 warning signs

No single metric tells the full story. See the ROCO:4194 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Holy Stone Healthcare Co Business Description

Address Number 88, Section 1, Neihu Road, 4th Floor, Neihu District, Taipei, TWN, 11493
Holy Stone Healthcare Co Ltd is a Taiwan based company focused on a biopolymer drug delivery platform. It is involved in the development of new drugs and medical devices, especially hyaluronic acid related therapeutic products. The products of the company include RenehaVis, SportVis, TRUD, and GAF.
45GF Score

Get the complete analysis for ROCO:4194

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$6.99
Price
NT$3.93
GF Value